Evidence map›Paper›PMID 27867686›Full record

ReviewWorld journal of gastrointestinal pharmacology and therapeutics2016

Widespread use of gastric acid inhibitors in infants: Are they needed? Are they safe?

Mark Safe, Wei H Chan, Steven T Leach, Lee Sutton, Kei Lui, Usha Krishnan

Abstract readReview
In one paragraph

Review in World journal of gastrointestinal pharmacology and therapeutics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Starch-based thickening in infant formula:Frontiers in nutrition · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Acid-suppressive medication and incidence of chronic childhood immune-mediated diseases: A scoping review.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2023
    Article
  11. Appropriateness of proton pump inhibitors use in noncritically ill hospitalized children in a tertiary hospital in Saudi Arabia.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023
    Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Does feeding modification strategies help improve reflux symptoms in NICU infants?Journal of perinatology : official journal of the California Perinatal Association · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mark SafeMark Safe, Usha Krishnan, Department of Paediatric Gastroenterology, Sydney Children's Hospital, Randwick NSW 2031, Australia.
Wei H ChanMark Safe, Usha Krishnan, Department of Paediatric Gastroenterology, Sydney Children's Hospital, Randwick NSW 2031, Australia.
Steven T LeachMark Safe, Usha Krishnan, Department of Paediatric Gastroenterology, Sydney Children's Hospital, Randwick NSW 2031, Australia.
Lee SuttonMark Safe, Usha Krishnan, Department of Paediatric Gastroenterology, Sydney Children's Hospital, Randwick NSW 2031, Australia.
Kei LuiMark Safe, Usha Krishnan, Department of Paediatric Gastroenterology, Sydney Children's Hospital, Randwick NSW 2031, Australia.
Usha KrishnanMark Safe, Usha Krishnan, Department of Paediatric Gastroenterology, Sydney Children's Hospital, Randwick NSW 2031, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastroesophageal reflux is a common phenomenon in infants, but the differentiation between gastroesophageal reflux and gastroesophageal reflux disease can be difficult. Symptoms are non-specific and there is increasing evidence that the majority of symptoms may not be acid-related. Despite this, gastric acid inhibitors such as proton pump inhibitors are widely and increasingly used, often without objective evidence or investigations to guide treatment. Several studies have shown that these medications are ineffective at treating symptoms associated with reflux in the absence of endoscopically proven oesophagitis. With a lack of evidence for efficacy, attention is now being turned to the potential risks of gastric acid suppression. Previously assumed safety of these medications is being challenged with evidence of potential side effects including GI and respiratory infections, bacterial overgrowth, adverse bone health, food allergy and drug interactions.

Indexed as

Adverse eventsGastroesophageal refluxInfantsProton pump inhibitorsRanitidineSafety

Identifiers

PMID27867686
PMCPMC5095572

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.